253 related articles for article (PubMed ID: 33051665)
1. Transcriptional landscape of cholangiocarcinoma revealed by weighted gene coexpression network analysis.
Long J; Huang S; Bai Y; Mao J; Wang A; Lin Y; Yang X; Wang D; Lin J; Bian J; Yang X; Sang X; Wang X; Zhao H
Brief Bioinform; 2021 Jul; 22(4):. PubMed ID: 33051665
[TBL] [Abstract][Full Text] [Related]
2. Identification of hub genes and pathways in cholangiocarcinoma by coexpression analysis.
Kong J; Shen S; Zhang Z; Wang W
Cancer Biomark; 2020; 27(4):505-517. PubMed ID: 32116234
[TBL] [Abstract][Full Text] [Related]
3. Cholangiocarcinoma‑associated genes identified by integrative analysis of gene expression data.
Zhong W; Dai L; Liu J; Zhou S
Mol Med Rep; 2018 Apr; 17(4):5744-5753. PubMed ID: 29436659
[TBL] [Abstract][Full Text] [Related]
4. Weighted gene coexpression network analysis reveals hub genes involved in cholangiocarcinoma progression and prognosis.
Tian A; Pu K; Li B; Li M; Liu X; Gao L; Mao X
Hepatol Res; 2019 Oct; 49(10):1195-1206. PubMed ID: 31177590
[TBL] [Abstract][Full Text] [Related]
5. A comprehensive transcriptomic landscape of cholangiocarcinoma based on bioinformatics analysis from large cohort of patients.
Li H; Qu L; Zhang H; Liu J; Zhang X
Sci Rep; 2021 Jul; 11(1):13713. PubMed ID: 34211100
[TBL] [Abstract][Full Text] [Related]
6. Identification of transcription factors (TFs) and targets involved in the cholangiocarcinoma (CCA) by integrated analysis.
Yang L; Feng S; Yang Y
Cancer Gene Ther; 2016 Dec; 23(12):439-445. PubMed ID: 27857060
[TBL] [Abstract][Full Text] [Related]
7. Transcriptomic analysis and identification of prognostic biomarkers in cholangiocarcinoma.
Li H; Long J; Xie F; Kang K; Shi Y; Xu W; Wu X; Lin J; Xu H; Du S; Xu Y; Zhao H; Zheng Y; Gu J
Oncol Rep; 2019 Nov; 42(5):1833-1842. PubMed ID: 31545466
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of aberrantly expressed profiles of lncRNAs, miRNAs and mRNAs with associated ceRNA network in cholangiocarcinoma.
Wang X; Hu KB; Zhang YQ; Yang CJ; Yao HH
Cancer Biomark; 2018; 23(4):549-559. PubMed ID: 30452401
[TBL] [Abstract][Full Text] [Related]
9. A novel five-lncRNA signature panel improves high-risk survival prediction in patients with cholangiocarcinoma.
Xie X; Wang Y; Zhang S; Li J; Yu Z; Ding X; Ye L; Gong P; Zhu Q; Li J; Chen Z; Yao X; Du Z; Zeng Q; Chen H; Yang Z; Chen G
Aging (Albany NY); 2021 Jan; 13(2):2959-2981. PubMed ID: 33472169
[TBL] [Abstract][Full Text] [Related]
10. Identification and Validation of Novel Biomarkers and Potential Targeted Drugs in Cholangiocarcinoma: Bioinformatics, Virtual Screening, and Biological Evaluation.
Wang J; Zhu W; Tu J; Zheng Y
J Microbiol Biotechnol; 2022 Oct; 32(10):1262-1274. PubMed ID: 36224755
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive circular RNA expression profiling constructs a ceRNA network and identifies hsa_circ_0000673 as a novel oncogene in distal cholangiocarcinoma.
Zhao X; Zhang X; Zhang Z; Liu Z; Zhu J; Lyu S; Li L; Lang R; He Q
Aging (Albany NY); 2020 Nov; 12(22):23251-23274. PubMed ID: 33221765
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of gene expression profiles identifies differential biomarkers for hepatocellular carcinoma and cholangiocarcinoma.
Likhitrattanapisal S; Tipanee J; Janvilisri T
Tumour Biol; 2016 Sep; 37(9):12755-12766. PubMed ID: 27448818
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide identification of a competing endogenous RNA network in cholangiocarcinoma.
Li G; Liu T; Zhang B; Chen W; Ding Z
J Cell Biochem; 2019 Nov; 120(11):18995-19003. PubMed ID: 31270845
[TBL] [Abstract][Full Text] [Related]
14. Survival analysis of genome-wide profiles coupled with Connectivity Map database mining to identify potential therapeutic targets for cholangiocarcinoma.
Lin P; Zhong XZ; Wang XD; Li JJ; Zhao RQ; He Y; Jiang YQ; Huang XW; Chen G; He Y; Yang H
Oncol Rep; 2018 Dec; 40(6):3189-3198. PubMed ID: 30272356
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-329-mediated PTTG1 downregulation inactivates the MAPK signaling pathway to suppress cell proliferation and tumor growth in cholangiocarcinoma.
Hu ZG; Zheng CW; Su HZ; Zeng YL; Lin CJ; Guo ZY; Zhong FD; Yuan GD; He SQ
J Cell Biochem; 2019 Jun; 120(6):9964-9978. PubMed ID: 30582202
[TBL] [Abstract][Full Text] [Related]
16. SOX2 knockdown slows cholangiocarcinoma progression through inhibition of transcriptional activation of lncRNA PVT1.
Yu A; Zhao L; Kang Q; Li J; Chen K; Fu H
Biochem J; 2020 Sep; 477(18):3527-3540. PubMed ID: 32812642
[TBL] [Abstract][Full Text] [Related]
17. Identification of 40S ribosomal protein S8 as a novel biomarker for alcohol‑associated hepatocellular carcinoma using weighted gene co‑expression network analysis.
Bi N; Sun Y; Lei S; Zeng Z; Zhang Y; Sun C; Yu C
Oncol Rep; 2020 Aug; 44(2):611-627. PubMed ID: 32627011
[TBL] [Abstract][Full Text] [Related]
18. Bioinformatics Analysis Identifies the Estrogen Receptor 1 (ESR1) Gene and hsa-miR-26a-5p as Potential Prognostic Biomarkers in Patients with Intrahepatic Cholangiocarcinoma.
Qin X; Song Y
Med Sci Monit; 2020 May; 26():e921815. PubMed ID: 32435051
[TBL] [Abstract][Full Text] [Related]
19. lnc-PKD2-2-3, identified by long non-coding RNA expression profiling, is associated with pejorative tumor features and poor prognosis, enhances cancer stemness and may serve as cancer stem-cell marker in cholangiocarcinoma.
Qiu G; Ma D; Li F; Sun D; Zeng Z
Int J Oncol; 2019 Jul; 55(1):45-58. PubMed ID: 31059014
[TBL] [Abstract][Full Text] [Related]
20. MORC2 promotes cell growth and metastasis in human cholangiocarcinoma and is negatively regulated by miR-186-5p.
Liao G; Liu X; Wu D; Duan F; Xie X; Wen S; Li Y; Li S
Aging (Albany NY); 2019 Jun; 11(11):3639-3649. PubMed ID: 31180332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
